TNF and rheumatoid arthritis: Despite being already present in some RA therapies and achieving good therapeutic results, blockade of TNF-α signaling cannot be universally and commonly used due to a large group of patients not responding to this type of treatment [138,139] because of differences in disease phenotypes.